VRTX VERTEX PHARMACEUTICALS INC / MA

NEUTRAL Impact: 2/10 Insider Cluster (2 insiders)
Horizon days Filed Jun 3, 2026 Processed 11d 12h ago
Insider cluster: 2 insiders, $1.3M total
Latest settled — T+1d
VRTX ▲ +1.13% at T+1d
NEUTRAL call ✓ call won +1.13% · α vs SPY +3.73% · entry $441.47 → $446.47
Next anchor: T+5d due 5d ago
Last close $444.93 (close Jun 12) · +0.78% from $441.47 entry
Entry anchored
Jun 3, 2026
via day open
T+1d
+1.13%
call +1.13% · α +3.73%
$446.47
settled 11d ago
T+5d
call — · α —
due 5d ago
T+20d
call — · α —
in 17d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Two senior executives at Vertex Pharmaceuticals (EVP/CMO and EVP/Chief Legal Officer) sold a combined $1.25M in open-market sales over a 4-day window. The total value represents ~0.001% of Vertex's $107.9B market cap — a trivial amount. No insider buying occurred. The sales are routine in size and context, with no material signal for the stock.

Key Financial Metrics

Direction
selling
Total Value
$1.3M
Insiders
2

Actionable Insight

The insider sales are immaterial relative to Vertex's market cap and likely reflect routine diversification or tax planning. No bearish signal. Monitor upcoming earnings or pipeline catalysts for directional moves; this cluster has no standalone trading implication.

Key Facts

  • EVP and CMO Carmen Bozic sold 1,974 shares at $450.00 for $888,300 on 2026-05-29.
  • EVP and Chief Legal Officer Joy Liu sold 828 shares at $439.91 for $364,245 on 2026-06-01.
  • Total insider sales in the cluster: $1.25M, or ~0.001% of Vertex's $107.9B market cap.
  • No insider purchases were reported in the cluster window.
  • Recent 30-day insider activity shows 5 sells totaling $5.0M — consistent with routine portfolio diversification.
  • Historical performance on VRTX reports shows a 10% win rate at T+20 across 10 settled reports, with avg alpha of -5.21%.

Financial Impact

Total insider sales of $1.25M, representing ~0.001% of market cap — economically negligible.

insider_activity

Risk Factors

  • No material risk identified from this cluster — sales are trivial in size.
  • Vertex's historical T+20 performance on prior reports has been poor (10% win rate), but this is a neutral event with no directional call.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (40 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-VRTX-1780517228070
10 reports for VRTX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for VRTX — sortable, filterable
Type Now
Jun 3, 2026
11d ago
Insider Cluster
NEUTRAL ★ 2/10
$441.47 $446.47▲ +1.13%▲ +3.73%$444.93 (+0.78%)
May 31, 2026
14d ago
ANALYST-UPGRADE
BULLISH ★ 1/10
$451.61 $456.17▲ +1.01%▲ +1.28%$444.93 (−1.48%)
May 19, 2026
26d ago
Insider Cluster
NEUTRAL ★ 2/10
$430.05 $433.38▲ +0.77%▲ +0.58%$444.93 (+3.46%)
May 1, 2026
6w ago
ANALYST-UPGRADE
MIXED ★ 1/10
$451.61 $456.17▲ +1.01%▲ +1.28%$444.93 (−1.48%)
Mar 11, 2026
13w ago
Insider Cluster
NEUTRAL ★ 3/10
$491.96 $477.98▼ −2.84%▼ −1.36%$444.93 (−9.56%)
Feb 25, 2026
15w ago
Insider Cluster
NEUTRAL ★ 4/10
$482.92 $480.12▼ −0.58%▼ −0.03%$444.93 (−7.87%)
Feb 25, 2026
15w ago
Insider Cluster
BEARISH ★ 6/10
$482.92 $480.12▲ +0.58%▲ +0.03%$444.93 (+7.87%)
Feb 25, 2026
15w ago
Insider Cluster
NEUTRAL ★ 3/10
$482.92 $480.12▼ −0.58%▼ −0.03%$444.93 (−7.87%)
Feb 25, 2026
15w ago
Insider Cluster
NEUTRAL ★ 4/10
$482.92 $480.12▼ −0.58%▼ −0.03%$444.93 (−7.87%)
Feb 25, 2026
15w ago
Insider Cluster
NEUTRAL ★ 3/10
$482.92 $480.12▼ −0.58%▼ −0.03%$444.93 (−7.87%)
Showing 10 of 10

US Market Status

Market Closed — Opens in 4h 39m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access